1. Home
  2. SCLX vs AMTX Comparison

SCLX vs AMTX Comparison

Compare SCLX & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$9.03

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$1.59

Market Cap

98.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
AMTX
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
98.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
AMTX
Price
$9.03
$1.59
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$17.00
AVG Volume (30 Days)
80.8K
1.1M
Earning Date
11-14-2025
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$201,323,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
$139.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$1.22
52 Week High
$34.27
$3.66

Technical Indicators

Market Signals
Indicator
SCLX
AMTX
Relative Strength Index (RSI) 34.71 50.47
Support Level $7.82 $1.55
Resistance Level $10.41 $1.83
Average True Range (ATR) 1.02 0.15
MACD 0.05 0.00
Stochastic Oscillator 20.56 37.89

Price Performance

Historical Comparison
SCLX
AMTX

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: